Company profile for Ensysce Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ensysce intends to launch the first new class of Opioid analgesics in decades —limiting the chances for abuse while alleviating pain. We’re a biotech company committed to stemming the prescription drug abuse epidemic. Our proprietary prodrug technologies: abuse resistant TAAP™ and overdose resistant MPAR™ are designed to improve the care of patients with chronic pain while reducing the human and economic costs ass...
Ensysce intends to launch the first new class of Opioid analgesics in decades —limiting the chances for abuse while alleviating pain. We’re a biotech company committed to stemming the prescription drug abuse epidemic. Our proprietary prodrug technologies: abuse resistant TAAP™ and overdose resistant MPAR™ are designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription drug abuse.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3210 Merryfield Row San Diego, CA 92121
Telephone
Telephone
(858) 242-1553
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-11-20/ensysce-biosciences-receives-positive-fda-feedback-on-pf614-manufacturing-approach

PHARMIWEB
20 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-17/ensysce-biosciences-secures-4-million-financing-unlocking-up-to-20-million-in-total-financing-to

PHARMIWEB
17 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-14/ensysce-biosciences-reports-third-quarter-2025-financial-results

PHARMIWEB
14 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-10/ensysce-biosciences-releases-symposium-highlights-from-painweek-2025

PHARMIWEB
10 Oct 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ensysce-biosciences-showcases-urgent-need-for-safer-opioids-at-painwe-1068649

ACCESSWIRE
04 Sep 2025

https://www.pharmiweb.com/press-release/2025-08-19/ensysce-biosciences-geoff-birkett-to-chair-the-fierce-new-product-planning-summit-2025

PHARMAWEB
19 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty